Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

ARA 290 Same as ARA-290: Peptide Comparison

Amino Acid Length 11 residues 165 residues 165 residues + modified glycosylation ARA 290 is a fragment, not a full protein Molecular Weight ~1.3 kDa ~30 kDa ~37 kDa ARA 290 is 25× smaller than EPO Receptor Target Innate repair receptor (βCR + EPOR heterodimer)

This comparison does not assign a generated winner or score.

  • Amino Acid Length
  • 11 residues
  • 165 residues
  • 165 residues + modified glycosylation
  • ARA 290 is a fragment, not a full protein
  • Molecular Weight
  • ~1.3 kDa
  • ~30 kDa
  • ~37 kDa
  • ARA 290 is 25× smaller than EPO
  • Receptor Target
  • Innate repair receptor (βCR + EPOR heterodimer)
  • EPOR homodimer
  • Only ARA 290 avoids erythropoietic activation
  • Erythropoietic Activity
  • None. No red blood cell production
  • High. Primary function
  • High. Extended half-life version
  • ARA 290 eliminates hematocrit risk entirely
  • Plasma Half-Life
  • 30–60 minutes
  • 6–8 hours
  • 25 hours
  • Shorter half-life limits systemic exposure
  • Clinical Application
  • Tissue protection, neuropathy, inflammation
  • Anemia, chronic kidney disease
  • Anemia in cancer, CKD
  • ARA 290 targets repair, not hematopoiesis
More references

Related material

Comparison

ARA-290 vs other healing peptides

Researchers exploring tissue repair and pain relief have several peptide options. Understanding how ARA-290 compares to alternatives like BPC-157 and TB-500 helps with protocol pl…

View details →
Comparison

ARA-290 vs BPC-157

BPC-157, a 15-amino acid peptide derived from human gastric juice, has robust preclinical evidence for musculoskeletal repair, particularly tendons and ligaments. It also shows ne…

View details →
Comparison

ARA-290 vs TB-500

TB-500, a synthetic version of thymosin beta-4's active fragment, promotes tissue regeneration through effects on cell migration and angiogenesis. It works more systemically than …

View details →